Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05400512 · ClinicalTrials.gov registry record · NA

Cognitive Enhancement in Depression (The COG-D Study)

A NA study of Depression and Aging, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT05400512 is a NA study of Depression and Aging that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 16 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05400512, a NA study of Depression and Aging, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This study will investigate whether transcranial direct current stimulation (tDCS) enhances the effects of computerized cognitive training in older adults with recurrent depression (2 or more lifetime episodes; either current or within past 3 years).

Interventions

  • BEHAVIORAL Cognitive Training
  • DEVICE tDCS (active stimulation)
  • DEVICE tDCS (sham stimulation)

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2023-02-08
Est. Completion 2025-08-18
Phase NA

What the Registry Record Tells You About NCT05400512

The ClinicalTrials.gov registry entry for NCT05400512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Training is the first listed.

NCT05400512 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT05400512 about?

NCT05400512 is a clinical study titled "Cognitive Enhancement in Depression (The COG-D Study)". This study will investigate whether transcranial direct current stimulation (tDCS) enhances the effects of computerized cognitive training in older adults with recurrent depression (2 or more lifetime episodes; either current or within past 3 years).

What is the current status of trial NCT05400512?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2023-02-08. Estimated completion is 2025-08-18.

What conditions does trial NCT05400512 study?

This clinical trial studies the following conditions: Depression, Aging, Cognitive Symptom.

What interventions are being tested in trial NCT05400512?

The interventions under investigation include: Cognitive Training (BEHAVIORAL), tDCS (active stimulation) (DEVICE), tDCS (sham stimulation) (DEVICE).

Who is sponsoring clinical trial NCT05400512?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05400512 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.